• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外显子组测序在疑似遗传性疾病患儿中的成本和诊断产量:基准研究。

The cost and diagnostic yield of exome sequencing for children with suspected genetic disorders: a benchmarking study.

机构信息

Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.

Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

Genet Med. 2018 Sep;20(9):1013-1021. doi: 10.1038/gim.2017.226. Epub 2018 Jan 4.

DOI:10.1038/gim.2017.226
PMID:29300375
Abstract

PURPOSE

This study aimed to generate benchmark estimates for the cost, diagnostic yield, and cost per positive diagnosis of diagnostic exome sequencing (ES) in heterogeneous pediatric patient populations and to illustrate how the design of an ES service can influence its cost and yield.

METHODS

A literature review and Monte Carlo simulations were used to generate benchmark estimates for singleton and trio ES. A cost model for the Clinical Assessment of the Utility of Sequencing and Evaluation as a Service (CAUSES) study, which is testing a proposed delivery model for diagnostic ES in British Columbia, is used to illustrate the potential effects of changing the service design.

RESULTS

The benchmark diagnostic yield was 34.3% (95% confidence interval (CI): 23.2-46.5) for trio ES and 26.5% (95% CI: 12.9-42.9) for singleton ES. The benchmark cost of delivery was C$6,437 (95% CI: $5,305-$7,704) in 2016 Canadian dollars (US$4,859; 4,391€) for trio ES and C$2,576 (95% CI: $1,993-$3,270) (US$1,944; 1,757€) for singleton ES. Scenario models for CAUSES suggest that alternative service designs could reduce costs but might lead to a higher cost per diagnosis due to lower yields.

CONCLUSION

Broad conclusions about the cost-effectiveness of ES should be drawn with caution when relying on studies that use cost or yield assumptions that lie at the extremes of the benchmark ranges.

摘要

目的

本研究旨在为异质性儿科患者群体中诊断外显子组测序(ES)的成本、诊断产量和每阳性诊断的成本生成基准估计值,并说明 ES 服务的设计如何影响其成本和产量。

方法

文献回顾和蒙特卡罗模拟用于生成单体和三体型 ES 的基准估计值。使用不列颠哥伦比亚省正在测试的诊断 ES 拟议交付模型的临床评估效用测序和作为服务的评估(CAUSES)研究的成本模型来说明改变服务设计的潜在影响。

结果

三体型 ES 的基准诊断产量为 34.3%(95%置信区间(CI):23.2-46.5),单体 ES 为 26.5%(95%CI:12.9-42.9)。2016 年加拿大元(US$4,859;4,391€)的三体型 ES 交付基准成本为 6437 加元(95%CI:5305-7704),单体 ES 为 2576 加元(95%CI:1993-3270)(US$1,944;1,757€)。CAUSES 的情景模型表明,替代服务设计可以降低成本,但由于产量较低,每诊断的成本可能会更高。

结论

在依赖成本或产量假设处于基准范围极端的研究来得出关于 ES 的成本效益的广泛结论时,应谨慎行事。

相似文献

1
The cost and diagnostic yield of exome sequencing for children with suspected genetic disorders: a benchmarking study.外显子组测序在疑似遗传性疾病患儿中的成本和诊断产量:基准研究。
Genet Med. 2018 Sep;20(9):1013-1021. doi: 10.1038/gim.2017.226. Epub 2018 Jan 4.
2
A head-to-head evaluation of the diagnostic efficacy and costs of trio versus singleton exome sequencing analysis.三基因组合与单基因外显子组测序分析的诊断功效和成本的头对头评估。
Eur J Hum Genet. 2019 Dec;27(12):1791-1799. doi: 10.1038/s41431-019-0471-9. Epub 2019 Jul 18.
3
Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness.将外显子组测序纳入癫痫性脑病的诊断路径:临床实用性和成本效益的证据。
Mol Genet Genomic Med. 2018 Mar;6(2):186-199. doi: 10.1002/mgg3.355. Epub 2018 Jan 4.
4
The cost trajectory of the diagnostic care pathway for children with suspected genetic disorders.疑似遗传疾病儿童诊断护理路径的成本轨迹。
Genet Med. 2020 Feb;22(2):292-300. doi: 10.1038/s41436-019-0635-6. Epub 2019 Aug 29.
5
Exome Sequencing for Prenatal Detection of Genetic Abnormalities in Fetal Ultrasound Anomalies: An Economic Evaluation.针对胎儿超声异常的产前遗传异常的外显子组测序:经济评估。
Fetal Diagn Ther. 2020;47(7):554-564. doi: 10.1159/000504976. Epub 2020 Jan 21.
6
Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from Canada.全基因组测序在发育和癫痫障碍中的真实世界诊断结果和成本效益:来自加拿大的证据。
Genet Med. 2024 Apr;26(4):101069. doi: 10.1016/j.gim.2024.101069. Epub 2024 Jan 8.
7
Narrowing the diagnostic gap: Genomes, episignatures, long-read sequencing, and health economic analyses in an exome-negative intellectual disability cohort.缩小诊断差距:基因组、外显子组特征、长读测序和外显子阴性智力障碍队列的健康经济分析。
Genet Med. 2024 May;26(5):101076. doi: 10.1016/j.gim.2024.101076. Epub 2024 Jan 19.
8
Bayesian cost-effectiveness analysis of Whole genome sequencing versus Whole exome sequencing in a pediatric population with suspected genetic disorders.贝叶斯成本效果分析全基因组测序与全外显子组测序在疑似遗传疾病的儿科人群中的应用。
Eur J Health Econ. 2024 Aug;25(6):999-1011. doi: 10.1007/s10198-023-01644-0. Epub 2023 Nov 17.
9
A single center experience with publicly funded clinical exome sequencing for neurodevelopmental disorders or multiple congenital anomalies.一项针对神经发育障碍或多发先天性畸形的公共资助临床外显子组测序的单中心经验。
Sci Rep. 2021 Sep 27;11(1):19099. doi: 10.1038/s41598-021-98646-w.
10
Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach.神经遗传学探索中的全外显子组测序:一种有效、节省成本和时间的诊断方法。
PLoS One. 2018 Feb 1;13(2):e0191228. doi: 10.1371/journal.pone.0191228. eCollection 2018.

引用本文的文献

1
Tracing the evolution of sequencing into the era of genomic medicine.追溯测序技术在基因组医学时代的发展历程。
Nat Rev Genet. 2025 Aug 15. doi: 10.1038/s41576-025-00884-5.
2
PhenoDP: leveraging deep learning for phenotype-based case reporting, disease ranking, and symptom recommendation.PhenoDP:利用深度学习进行基于表型的病例报告、疾病排名和症状推荐。
Genome Med. 2025 Jun 6;17(1):67. doi: 10.1186/s13073-025-01496-8.
3
Copy number variant analysis improves diagnostic yield in a diverse pediatric exome sequencing cohort.拷贝数变异分析提高了多样化儿科外显子组测序队列中的诊断率。
NPJ Genom Med. 2025 Feb 21;10(1):16. doi: 10.1038/s41525-025-00478-4.
4
The cost of genetic diagnosis of suspected hereditary pediatric cataracts with whole-exome sequencing from a middle-income country perspective: a mixed costing analysis.从中等收入国家角度看,采用全外显子组测序对疑似遗传性儿童白内障进行基因诊断的成本:一项混合成本分析
J Community Genet. 2024 Jun;15(3):235-247. doi: 10.1007/s12687-024-00708-9. Epub 2024 May 10.
5
Extending the new era of genomic testing into pregnancy management: A proposed model for Australian prenatal services.将基因组检测的新时代扩展到妊娠管理:澳大利亚产前服务的一个提议模型。
Aust N Z J Obstet Gynaecol. 2024 Oct;64(5):467-474. doi: 10.1111/ajo.13814. Epub 2024 Apr 5.
6
Genetic Discovery Enabled by A Large Language Model.由大语言模型实现的基因发现
bioRxiv. 2023 Nov 12:2023.11.09.566468. doi: 10.1101/2023.11.09.566468.
7
Diagnostic yield of pediatric and prenatal exome sequencing in a diverse population.多样化人群中儿科和产前外显子组测序的诊断率
NPJ Genom Med. 2023 May 26;8(1):10. doi: 10.1038/s41525-023-00353-0.
8
Cost of exome analysis in patients with intellectual disability: a micro-costing study in a French setting.智力障碍患者外显子组分析的成本:法国环境中的微观成本研究。
BMC Health Serv Res. 2023 Apr 21;23(1):386. doi: 10.1186/s12913-023-09373-z.
9
Applying whole exome sequencing in a consanguineous population with autism spectrum disorder.在一个患有自闭症谱系障碍的近亲婚配人群中应用全外显子组测序。
Int J Dev Disabil. 2021 Jun 21;69(2):190-200. doi: 10.1080/20473869.2021.1937000. eCollection 2023.
10
Genome-Wide Sequencing Modalities for Children with Unexplained Global Developmental Delay and Intellectual Disabilities-A Narrative Review.不明原因的全面发育迟缓及智力障碍儿童的全基因组测序方式——一篇叙述性综述
Children (Basel). 2023 Mar 3;10(3):501. doi: 10.3390/children10030501.